Galapagos
About:
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel.
Website: http://www.glpg.com
Twitter/X: GalapagosNV
Top Investors: Gilead Sciences, Gilde Healthcare, University of Antwerp, Thuja Capital, Van Herk Ventures
Description:
Galapagos is a clinical-stage biotechnology company, specialized in the discovery and development of small molecule medicines with novel modes of action. Our ambition is to become a leading global biopharmaceutical company, focused on the discovery, development and commercialization of innovative medicines that will improve people's lives.
$5.45B
$100M to $500M
Mechelen-bovelingen, Limburg, Belgium
1999-01-01
dpo(AT)glpg.com
Dinko Valerio, Onno Stolpe, Rudi Pauwels
251-500
2019-07-14
Public
© 2025 bioDAO.ai